Nova Eye Medical rounds out the program with real-world outcomes from the iTrack Global Data Registry at ESCRS 2026.

Public source

Publisher name

Public post

At ESCRS 2026, interventional glaucoma has the spotlight, and canaloplasty isn't just making a cameo.🎬 Nova Eye's program begins Saturday during the Instructional Cours…

Log in to read the full post

Company

Nova Eye Medical

Novel glaucoma treatment technologies spanning the entire disease spectrum.

Industry
Medical Device
Location
Fremont, US
Company size
51–200 employees

About Nova Eye Medical

Nova Eye Medical Limited is a medical technology company that develops, manufactures and sells a portfolio of proprietary glaucoma treatment technologies. Used by eye surgeons in more than 100 countries globally, these technologies include iTrack™ minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye’s natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications, and the Molteno3® glaucoma drainage device for cases of severe and complex glaucoma.

See more

Latest activity

10 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.